Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
Taiwan Semiconductor
TSM
ASML Holding
ASML
US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 23.090
- -0.270-1.16%
Close Mar 28 16:00 ET
- 23.090
- 0.0000.00%
Post 17:42 ET
1.68BMarket Cap-38.48P/E (TTM)
23.380High22.830Low1.54MVolume23.210Open23.360Pre Close35.67MTurnover6.64%Turnover RatioLossP/E (Static)72.64MShares28.15052wk High3.83P/B536.89MFloat Cap16.56052wk Low--Dividend TTM23.25MShs Float32.880Historical High--Div YieldTTM2.35%Amplitude5.010Historical Low23.090Avg Price1Lot Size
Kiniksa Pharmaceuticals International Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 93.14%25.69M | 333.99%18.77M | -113.16%-2.24M | 238.07%5.17M | 193.44%3.99M | 129.05%13.3M | 137.36%4.33M | -72.63%16.99M | 52.16%-3.74M | 88.42%-4.27M |
| Net income from continuing operations | -406.68%-43.19M | -135.22%-8.89M | 8.39%-12.69M | -126.10%-3.91M | -44.29%-17.7M | -92.32%14.08M | 465.73%25.24M | -106.18%-13.86M | 174.93%14.97M | 51.33%-12.27M |
| Operating gains losses | -113.41%-24K | --0 | --0 | ---- | ---- | 442.42%179K | -60.00%4K | --0 | --0 | --175K |
| Depreciation and amortization | -27.60%1.7M | -25.93%400K | -33.83%399K | -28.57%430K | -21.81%466K | -2.54%2.34M | -10.30%540K | 22.31%603K | -7.53%602K | -9.15%596K |
| Deferred tax | 124.07%8.13M | 87.70%-3.16M | -135.37%-3.64M | 154.36%10.57M | 305.29%4.37M | 81.78%-33.79M | -7,487.64%-25.71M | 105.54%10.29M | ---19.44M | --1.08M |
| Other non cash items | 2.69%3.14M | 4.07%767K | 6.65%754K | 8.71%836K | -7.37%779K | 0.43%3.05M | -6.47%737K | -8.42%707K | 3.08%769K | 14.42%841K |
| Change In working capital | 1,737.70%24.81M | 618.48%20.54M | -49.12%5.6M | -66.19%-9.91M | 3,199.23%8.58M | 105.98%1.35M | 83.46%-3.96M | -33.76%11.01M | -250.05%-5.96M | 101.35%260K |
| -Change in receivables | -2,053.47%-20.46M | 7.62%-16.84M | -120.53%-4.44M | 74.13%-4.46M | -59.11%5.27M | 94.18%-950K | -99.03%-18.23M | 744.85%21.61M | -179.63%-17.23M | 150.65%12.89M |
| -Change in inventory | 149.96%4.76M | 141.81%2.32M | 480.18%6.18M | -1,322.14%-7.58M | 310.51%3.84M | 46.87%-9.52M | 20.62%-5.54M | -130.69%-1.63M | 92.04%-533K | 80.88%-1.83M |
| -Change in prepaid assets | 61.65%-2.71M | 56.01%13.8M | 50.01%-6.99M | -1,971.23%-13.27M | 242.37%3.75M | -83.18%-7.07M | 81.70%8.85M | -971.80%-13.99M | 120.32%709K | 33.01%-2.63M |
| -Change in payables and accrued expense | 116.48%37.42M | -62.39%4.71M | 46.85%11.71M | 46.12%20.38M | 103.63%623K | 644.49%17.29M | 374.42%12.52M | 768.41%7.97M | 304.10%13.95M | -406.34%-17.16M |
| -Change in other current assets | -312.37%-9.74M | -279.52%-2.52M | ---10K | -4,165.56%-3.84M | -202.88%-3.36M | 72.72%4.58M | 630.57%1.41M | --0 | -155.21%-90K | 18.62%3.27M |
| -Change in other current liabilities | -23.97%-4.02M | -16.90%-927K | -18.28%-841K | -25.41%-997K | -32.98%-1.25M | -125.45%-3.24M | -2.85%-793K | -191.27%-711K | 1.12%-795K | -46.88%-943K |
| -Change in other working capital | 7,390.42%19.55M | 1,019.54%20M | 99.96%-1K | 92.16%-155K | -104.42%-294K | -97.83%261K | 84.78%-2.18M | -115.70%-2.24M | ---1.98M | -44.52%6.66M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 93.14%25.69M | 333.99%18.77M | -113.16%-2.24M | 238.07%5.17M | 193.44%3.99M | 129.05%13.3M | 137.36%4.33M | -72.63%16.99M | 52.16%-3.74M | 88.42%-4.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 227.46%37.67M | 538.38%65.29M | 48.29%-6.35M | -231.70%-46.8M | 167.31%25.52M | -265.90%-29.56M | 65.09%-14.89M | -164.48%-12.28M | -7.14%35.53M | -66.88%-37.92M |
| Net PPE purchase and sale | -93.85%-252K | -244.64%-193K | --0 | 173.53%25K | -250.00%-84K | -828.57%-130K | -233.33%-56K | 50.00%-16K | -41.67%-34K | ---24K |
| Net investment purchase and sale | 228.87%37.92M | 541.34%65.49M | 48.23%-6.35M | -231.64%-46.82M | 167.57%25.61M | -264.92%-29.43M | 65.25%-14.84M | -164.29%-12.26M | -7.11%35.57M | -66.77%-37.9M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 227.46%37.67M | 538.38%65.29M | 48.29%-6.35M | -231.70%-46.8M | 167.31%25.52M | -265.90%-29.56M | 65.09%-14.89M | -164.48%-12.28M | -7.14%35.53M | -66.88%-37.92M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 720.47%12.27M | 208.20%2.14M | 1,111.78%6.69M | -212.66%-178K | 3,914.44%3.61M | -40.58%1.5M | -41.60%695K | 52.91%552K | -70.85%158K | -78.72%90K |
| Net common stock issuance | -125.93%-4.98M | -120.61%-578K | -145.43%-2.71M | -213.37%-1.31M | 9.29%-381K | -144.84%-2.21M | -162.00%-262K | -431.25%-1.11M | -1,645.83%-419K | 26.19%-420K |
| Proceeds from stock option exercised by employees | 366.09%17.25M | 184.22%2.72M | 467.35%9.4M | 96.71%1.14M | 683.14%3.99M | 8.31%3.7M | -25.81%957K | 191.21%1.66M | 1.94%577K | -48.59%510K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 720.47%12.27M | 208.20%2.14M | 1,111.78%6.69M | -212.66%-178K | 3,914.44%3.61M | -40.58%1.5M | -41.60%695K | 52.91%552K | -70.85%158K | -78.72%90K |
| Net cash flow | ||||||||||
| Beginning cash position | -12.03%107.95M | -17.36%97.38M | -11.81%99.27M | 75.00%141.08M | -12.03%107.95M | 0.20%122.72M | -32.96%117.83M | 19.36%112.57M | 27.31%80.62M | 0.20%122.72M |
| Current changes in cash | 612.34%75.63M | 973.05%86.21M | -136.02%-1.9M | -230.86%-41.81M | 178.68%33.12M | -6,124.90%-14.76M | 81.39%-9.87M | -93.54%5.26M | 3.12%31.95M | 28.83%-42.1M |
| End cash Position | 70.05%183.58M | 70.05%183.58M | -17.36%97.38M | -11.81%99.27M | 75.00%141.08M | -12.03%107.95M | -12.03%107.95M | -32.96%117.83M | 19.36%112.57M | 27.31%80.62M |
| Free cash flow | 92.94%25.41M | 335.16%18.58M | -113.18%-2.24M | 236.83%5.17M | 190.96%3.9M | 130.99%13.17M | 136.98%4.27M | -72.64%16.97M | 52.42%-3.78M | 88.35%-4.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.